Gaurav Sahay — Dr. Gaurav Sahay's lab focuses on developing innovative gene therapy solutions for two major health issues: cystic fibrosis and inherited retinal degenerations. The lab works on creating advanced nanoparticle systems to deliver optimized mRNA and gene editing tools directly to targeted cells in the lungs and retina. By leveraging cutting-edge technologies such as microfluidics and AI-assisted design, the research aims to improve treatment effectiveness while minimizing invasiveness and side effects.
Ryan A Mehl — Dr. Ryan A. Mehl's lab at Oregon State University focuses on advancing Genetic Code Expansion (GCE) technology to enhance biomedical research. The lab aims to make the engineering of proteins with non-canonical amino acids more accessible to a wider range of researchers, creating powerful tools for investigating diseases and developing new therapeutics. Through training and community engagement, the lab will ensure that these methods are widely adopted in the scientific community.
David Charles Dallas — Dr. David Charles Dallas's lab at Oregon State University focuses on understanding how different handling practices of human milk affect the release and activity of beneficial peptides in the intestines of preterm infants. Through their research, they aim to discover the best methods to handle and fortify human milk to support healthy growth and development in neonates. This lab's work is crucial for improving nutrition strategies for preterm infants in neonatal intensive care units.
Olena Taratula — Dr. Olena Taratula's lab focuses on developing innovative diagnostic and treatment methods for ectopic pregnancies, a critical condition that can threaten maternal health. The lab leverages advanced technologies including nanoparticles to improve imaging of the placenta and magnetic hyperthermia techniques to non-invasively treat ectopic pregnancies. Such research aims to enhance the safety and effectiveness of maternal healthcare by providing better detection methods and therapeutic options.